Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Plan sponsors are encouraged to evaluate this cost-effective alternative, balancing it with regulatory considerations and the long-term needs of their members
Until oral GLP-1 formulations become widely available and proven for weight loss, Qsymia remains the strongest oral option
Retatrutide operates as a triple-agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, while traditional medications focus on single or dual targets
A 200-pound person targets 140 to 200 grams per day
Safety Considerations and Clinical Monitoring Safety is a central aspect of Retatrutide administration
Better animal protein
US$ 28.82
US$ 26.48
US$ 23.94
US$ 26.44
US$ 24.80
